# ProPhase Labs, Inc.: Form 8-K, filed Jul 28, 2025

- Company: [ProPhase Labs, Inc.](/companies/prph.md) (CIK 868278)
- Form: 8-K
- Filed: 2025-07-28
- Accepted by EDGAR: Jul 28, 2025, 12:20 ET
- Period: 2025-07-28
- Accession: 0001641172-25-021109
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/868278/000164117225021109/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/868278/000164117225021109/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/868278/000164117225021109/form8-k.htm

Filed Jul 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-021109. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.